pharmaphorum

AUGUST 3, 2022

It’s been more than two decades since the ground-breaking potential of using electronic health records (EHR) to inform clinical research was first mooted. Said Ibara: “If you compare the progress your phone has made since 1998, and the progress we have made in using healthcare data for clinical research, there’s a dramatic difference.

Cerner 122

Cerner FDA 122

pharmaphorum

MAY 19, 2022

The trial completed before the third booster doses were rolled out, and researchers say there is no data yet on whether the improvements reported after vaccines will be sustained with further follow-up.

Vaccines 122

Vaccines Immunization Communication 122

pharmaphorum

FEBRUARY 9, 2021

With the launch of Rare Central , Pulse Infoframe offers patient advocacy groups an on-ramp to collecting real-world data, including natural history data, disease-specific data, and patient-reported outcomes. Rare Central aims to change that, because it can connect patients around the world.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

SEPTEMBER 12, 2022

Mobile health specialist Happitech has launched software that it says can help researchers use photoplethysmography (PPG) technology in the development of applications for use in cardiovascular care. The post Happitech launches smartphone app for cardiac researchers appeared first on.

Hospitals 99

Hospitals 99

pharmaphorum

FEBRUARY 8, 2022

The latest agreement is with contract research organisation United BioSource (UBC), which will use Seqster’s expertise in collecting and analysing data from electronic health records (EHRs), genomic studies, wearables, and other sources in remote trial designs.

85

85

Pharma Mirror

AUGUST 30, 2021

CALGARY, AB: Reliable, consistent, and applicable data is a key feature of well-executed research and the development of new treatments. Lawrence Korngut, MD and Josh Lounsberry, MBA, and developed out of a lab at the Hotchkiss Brain Institute.

52

52

Pharmaceutical Technology

JUNE 15, 2023

Once the target is identified, researchers work to develop a compound that can interact with it. Algorithms can also predict the toxicity of a compound and its potential side effects, allowing researchers to focus their efforts on the most promising candidates.

Compounding 52

Compounding Adverse Reactions Dosage Documentation 52

NF2 BioSolutions

JULY 25, 2023

We have a new NF2 BioSolutions UK funded research paper out! As an NF2 research team funded by NF2 BioSolutions UK and Europe we want to understand how vestibular schwannoma grow so that appropriate clinical trials and drug choices can be made. And finally, research findings in the samples from one group (i.e

Immunization 98

Immunization Communication 98

Blog: Ask a Student Pharmacist

JULY 27, 2023

He supports clinical development in the oncology area, including protocol planning, study execution, and pharmacokinetics and pharmacogenomics data collection and analysis.

52

52

pharmaphorum

JULY 4, 2022

With a broad and diverse range of symptoms and severities impacting patients around the world, connecting these individuals with the information and expertise needed to achieve the correct diagnosis can be extremely lengthy and pose a significant barrier to treatment. “As Navigating rare disease research and treatment.

Hospitals 105

Hospitals 105

Pharmaceutical Technology

APRIL 11, 2023

Under the FDA’s drug safety Sentinel Initiative, the partnership will develop AI tools to collect key information from clinical notes within electronic health records (EHR). Connected technologies and unified data can accelerate innovation and, in turn, help providers realise better recommendations and outcomes for their patients.”

Cerner 59

Cerner FDA Hospitals 59

pharmaphorum

SEPTEMBER 28, 2022

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program at the National Institutes of Health (NIH), tells pharmaphorum about the programme and how it will accelerate research for the benefit of all patients. Gathering data.

FDA 95

FDA Dosage Documentation Pharmaceutical Companies 95

Roots Analysis

OCTOBER 29, 2023

Clinical trials are prospective biomedical research studies designed to evaluate medical, surgical or behavioral interventions in people and investigate novel approaches for the diagnosis and prevention / treatment of diseases. In such designs, the participants need not travel to a clinical research site or facility or a doctor’s clinic.

Health and Personal Care Stores 40

Health and Personal Care Stores Adverse Reactions Hospitals Pharmaceutical Companies 40

pharmaphorum

JANUARY 18, 2023

However, the Resilience Project’s scientists had used genomic data originally collected for other studies and, due to limitations in the original studies’ informed consent policies and a lack of infrastructure to recontact participants, none of the 13 individuals could be contacted with follow-up questions or requests.

Communication 93

Communication Medical Schools Insurance Pharmaceutical Companies 93

Pharma Marketing Network

JULY 19, 2023

However, these methods are becoming less effective as consumers are increasingly turning to digital channels for information and research. These platforms can be used to connect with patients and healthcare providers, share educational content, and build relationships.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies 96

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Improving the design of commercial research by listening to the patient voice. Gaining patient input on marketing and recruitment materials.

Documentation 115

Documentation Pharmaceutical Companies Pharmaceutical Companies Hospitals 115

pharmaphorum

AUGUST 11, 2022

That’s the conclusion of analysts at Morgan Stanley, Deutsche Bank and UBS, who have all issued research notes drawing attention to the issue, which has remained largely off the radar since sales of Zantac (ranitidine) were halted.

FDA 105

FDA 105

pharmaphorum

APRIL 11, 2022

Garabedian and his team plan to support VivoSense, not just with their funding package but with their industry network and connectivity. “We With their team’s collective experience in the field, Tabakin and his investors believe VivoSense is best positioned to provide these solutions. The inherent value of passive data collection.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Packaging 110

pharmaphorum

DECEMBER 11, 2022

Additionally, evidence generation encompasses new digital biomarkers and patient-facing platforms that can help collect them. About half of our talents come from the life sciences industry and clinical research, and the other half come from the tech world – so, totally different backgrounds,” Hadjiat said. “We

Hospitals 137

Hospitals 137

Blog: Ask a Student Pharmacist

JULY 24, 2023

Mathiowetz, PhD, OTR/L, FAOTA eomizowh Mon, 07/24/2023 - 14:03 Expand all + Biography Research Research Summary/Interests Fatigue management in chronic conditions, multiple sclerosis, task-oriented approach to CNS dysfunction, stroke, functional outcomes, motor control & motor learning, assessment of hand strength, dexterity, and hand function.

52

52

PQA

OCTOBER 19, 2022

In her current role, she collects and analyzes data to determine how the plan can improve member outcomes by using quality measures. Farquhar, Executive Vice President, Research, Quality & Scientific Affairs at American Urological Association, began her career as a nurse but quickly realized she wanted to be able to reach more people.

40

40

ISPE

MAY 2, 2023

We know that for both new therapies and traditional therapies, there is opportunity to leverage innovative manufacturing processes, collective guidance, and an agile mindset to adapt to the current needs of patients. That research also shows that 75% of companies are not yet seeing any value from their programs”.

98

98

pharmaphorum

MAY 19, 2022

Without careful consideration and full stakeholder input, the EU’s plans for a connected data system could end up being counterproductive. The EFPIA Recommendations on a Connected Data System in Europe, published at the end of April, welcomes the proposals, which are part of the European Strategy for Data, to create common data spaces.

Insurance 52

Insurance 52

pharmaphorum

JULY 8, 2022

Preliminary research suggests that hybrid DCTs can reduce trial timing and resources , improve patient-centricity and patient engagement , and expand access and recruitment and increase diversity , mitigate bias, and reinforce inclusion in clinical trials. New sensor technology revolutionising data collection.

FDA 89

FDA 89

The People's Pharmacy

APRIL 20, 2023

The current director of the Harvard Study of Adult Development shares the findings from this long-running, in-depth research on the factors that lead to happiness and a meaningful life. For the participants in the study, connections with other people were a keystone. As the study proceeded, new methods also became available.

Medical Schools 73

Medical Schools Hospitals 73

Hospital Pharmacy Europe

FEBRUARY 18, 2023

Having one of several autoimmune diseases have been found to increase the risk of developing new-onset atrial fibrillation over time Patients with autoimmune diseases (AIDs) are at an elevated risk of subsequently developing atrial fibrillation according to the findings of a prospective study by Dutch researchers.

Hospitals 52

Hospitals 52

pharmaphorum

JULY 5, 2022

George Freeman, minister for science, research and innovation at the Department for Business, Energy and Industrial Strategy, opened proceedings by reminding us of some of the UK’s recent achievements and aspirations for the future. Aspirations for the UK in life sciences. Faster access for patients for interventions.

Communication 98

Communication 98

pharmaphorum

DECEMBER 13, 2022

The COVID-19 pandemic created an urgent need to reach out and connect with study participants without them coming into clinics and risking infection. If researchers leverage these and other wearable devices for BYOD eCOA data collection, it makes the process simpler, smoother, and more cost-effective.

Data Entry 58

Data Entry HIPAA Insurance Communication 58

ISPE

OCTOBER 28, 2022

During SATs, all field equipment is connected and operational. The objective of our research: What techniques and procedures are required to enable reliable remote acceptance testing of automation projects? Research Objective. Research Questions. Research Design. Philosophical Overview.

Communication 52

Communication Documentation FDA 52

pharmaphorum

FEBRUARY 26, 2021

For Rare Disease Day, RBW Consulting’s Emma Thorp discusses why the consultancy is taking revenue earned from its rare disease clients and using it to fund research into the mental health impact of a rare disease diagnosis. The moment a rare disease diagnosis connects patients. What does the research hope to achieve?

Hospitals 110

Hospitals 110

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Communication 91

Communication Documentation Hospitals Vaccines 91

pharmaphorum

NOVEMBER 20, 2020

Behind the Mask is a global research initiative to document health experiences during the COVID-19 pandemic and beyond. Havas Health & You (HH&Y) has launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study that focuses on documenting the ongoing evolution of health and wellness.

Documentation 52

Documentation Communication Medication Delivery 52

PQA

FEBRUARY 9, 2024

Review these opportunities in the Sponsorship Prospectus, learn more below and connect with me. Snyder will explain the benefits and challenges of using a mobile application to collect PRO data on medication adherence in pharmacies. If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email!

59

59

pharmaphorum

APRIL 8, 2022

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve the correct diagnosis can be a significant barrier to treatment. . This is where modern technologies and data-driven medical informatics can bridge gaps in RD research. .

Hospitals 61

Hospitals 61

Hospital Pharmacy Europe

JANUARY 20, 2023

With an element of uncertainty surrounding the role of lipids and fracture risk, in the current study, the Australian team sought to clarify this connection. The researchers used regression analysis, adjusting for various factors including age, gender, physical activity and measures of fragility.

Hospitals 52

Hospitals 52

European Pharmaceutical Review

FEBRUARY 28, 2023

This issue of standards is a major topic that comes up at every event I attend related to laboratory research. To achieve data integration, we must first address the data standards issues…research labs must carefully consider the software they use to create their data and what formats they can produce it in.”

Documentation 92

Documentation 92

Pharmaceutical Technology

JUNE 15, 2023

Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field. AI-driven processes are often more efficient and cost-effective than traditional research methods, which take years or even decades to produce successful treatments.

Compounding 52

Compounding Patient Care 52